NPL: Barrier, Animal Source, Intraoral

Product code NPL, “Barrier, Animal Source, Intraoral” in FDA's classification database, is a Class II device type under 21 CFR 872.3930 (bone grafting material), reviewed by FDA's Dental panel. FDA's 510(k) database lists 57 clearances under NPL, 37 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
NPL
Regulation
21 CFR 872.3930
Class
II
Panel
Dental
Clearances
57
Most recent
Dec 12, 2025
Median review, last 2 years
132 days
Third-party review
Not eligible
Implant
Yes

What it covers

An animal source dental barrier is an animal-derived material device, such as collagen, intended to aid in guided tissue/bone regeneration procedures and to act as a stable barrier for the containment of bone graft materials when placed around implants.

FDA’s definition of product code NPL, from the Product Classification database.

FDA flags NPL devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K242817Jason membraneBotiss Biomaterials GmbHDec 12, 2025Traditional
K250512Augmented Gingival MatrixNeo Modulus (Suzhou) Medical Sci-Tech Co., Ltd.Dec 5, 2025Traditional
K252253Geistlich Mucograft® /Geistlich Mucograft® Seal; Geistlich Fibro-Gide®Geistlich Pharma AGNov 25, 2025Traditional
K251062Geistlich Bio-Gide; Geistlich Bio-Gide® Shape; Geistlich Bio-Gide® Compressed; Geistlich Bio-Gide® Forte; Geistlich Bio-Gide® Perio; Geistlich Combi-Kit Collagen®; Geistlich Perio-System Combi PackGeistlich Pharma AGAug 14, 2025Traditional
K250833SwissMembrane X; SwissMembrane X SocketGeistlich Pharma AGApr 15, 2025Special
K233203Soft Tissue Augmentation Resorbable MatrixCollagen Matrix, Inc.May 1, 2024Traditional
K231513Oral MatrixBeijing Biosis Healing Biolog Ical Technology Co., Ltd.Feb 16, 2024Traditional
K231305Endoform Dental MembraneAroa Biosurgery , Ltd.Jan 23, 2024Traditional
K230091THE CoverPurgo Biologics, Inc.Oct 6, 2023Traditional
K223912InterCollagen® GuideSigmagraft, Inc.Aug 17, 2023Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 57 with a free account)

Clearances by year

37 NPL 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
20255132
20243263
20232249
20223290
20212139
20202314
2019129
20181234
20173200
20163184
20151496
20145140
20132733
20114286

Who submits

24 applicants cleared a NPL device since 2011. 35% of the clearances went to applicants in United States, then Switzerland (24%), Israel (8%) and China (5%). By type: Traditional 89% and Special 11%.

ApplicantClearances since 2011
Geistlich Pharma AG9
Collagen Matrix, Inc.4
Datum Dental, Ltd.3
Aroa Biosurgery , Ltd.1
Beijing Biosis Healing Biolog Ical Technology Co., Ltd.1
Biom'Up Sas1
Botiss Biomaterials GmbH1
Collamatrix, Inc.1

How FDA classifies it

(1) Class II (special controls) for bone grafting materials that do not contain a drug that is a therapeutic biologic. The special control is FDA's “Class II Special Controls Guidance Document: Dental Bone Grafting Material Devices.” (See § 872.1(e) for the availability of this guidance document.)

(2) Class III (premarket approval) for bone grafting materials that contain a drug that is a therapeutic biologic. Bone grafting materials that contain a drug that is a therapeutic biologic, such as biological response modifiers, require premarket approval.

From 21 CFR 872.3930. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 872.3930 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent NPL clearances declared.

Ask about NPL

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about NPL

What is FDA product code NPL?

Product code NPL, “Barrier, Animal Source, Intraoral” in FDA's classification database, is a Class II device type under 21 CFR 872.3930 (bone grafting material), reviewed by FDA's Dental panel. FDA's 510(k) database lists 57 clearances under NPL, 37 of them since 2011.

How many 510(k) clearances are there under NPL?

FDA’s 510(k) database listed 57 clearances under NPL as of Oct 29, 2026, 37 of them decided since 2011; the most recent decision was Dec 12, 2025. The Predicate Finder searches the live database.

How long does FDA take to clear a NPL 510(k)?

For the 5 NPL clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 132 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most NPL clearances?

Since 2011: Geistlich Pharma AG (9), Collagen Matrix, Inc. (4), Datum Dental, Ltd. (3), Aroa Biosurgery , Ltd. (1) and Beijing Biosis Healing Biolog Ical Technology Co., Ltd. (1). 24 applicants have cleared a NPL device in that time.

Sources

  1. FDA product classification: NPL · Product Classification database
  2. 21 CFR 872.3930: Bone grafting material · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for NPL · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow NPLGet an email when FDA clears, recalls or publishes guidance for NPL devices.

Know what FDA already cleared.